Home Tirzepatide Side effects Constipation
Tirzepatide and Constipation
Roughly 11–17% of participants — more commonly reported with tirzepatide than with semaglutide in indirect comparisons, and often the longest-lasting effect.
Roughly 11–17% of participants of participants in the tirzepatide trial program reported constipation — more commonly reported with tirzepatide than with semaglutide in indirect comparisons, and often the longest-lasting effect.
Slowed gastrointestinal motility, combined with reduced food volume and frequently reduced fluid and fiber intake, produces harder and less frequent stools. Tends to appear in the first month and, unlike nausea, can persist for months rather than resolving with adaptation.
Frequencies are approximate ranges from the published trial program and differ by dose, population and how events were collected. They are not a prediction for any individual.
| Reported frequency | Roughly 11–17% of participants |
|---|---|
| Typical onset | Tends to appear in the first month and, unlike nausea, can persist for months rather than resolving with adaptation. |
| Mechanism | Slowed gastrointestinal motility, combined with reduced food volume and frequently reduced fluid and fiber intake, produces harder and less frequent stools. |
| Usually resolves | Variable — see below |
| Requires urgent review | Only if a red-flag symptom below is present |
Why tirzepatide causes constipation
Slowed gastrointestinal motility, combined with reduced food volume and frequently reduced fluid and fiber intake, produces harder and less frequent stools.
When constipation starts and how long it lasts
Tends to appear in the first month and, unlike nausea, can persist for months rather than resolving with adaptation.
How to manage constipation on tirzepatide
- Increase fiber gradually rather than suddenly, because a large jump on a slowed gut can worsen bloating
- Raise fluid intake deliberately, since appetite suppression reduces drinking as well as eating
- Walk daily; movement is one of the few reliable motility interventions
- Ask your prescriber about a stool softener or an osmotic laxative rather than self-treating long term
- Review any other constipating medications you take
Constipation: when to contact a clinician
Seek medical advice promptly if any of the following occurs:
- No bowel movement for several days combined with abdominal pain, distension or vomiting
- Blood in the stool
- Sudden severe abdominal pain
Does constipation mean the tirzepatide dose is wrong?
Not necessarily. Adverse effects on tirzepatide cluster in the days after a dose increase and typically settle as the gut adapts. The usual response to a poorly tolerated step is to hold the current strength for another four weeks rather than to stop treatment or to climb faster. That decision belongs to your prescriber.
Frequently asked questions
Why is constipation worse on tirzepatide than semaglutide?
The dual GIP/GLP-1 mechanism appears to affect gut motility somewhat differently. Indirect comparisons report higher constipation rates.
Can I take fiber supplements?
Often yes, introduced slowly and with adequate fluid. Confirm with your prescriber, particularly if motility is already very slow.
People also ask about tirzepatide constipation
What is tirzepatide constipation?
Tirzepatide constipation is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does tirzepatide constipation apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does tirzepatide constipation cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is tirzepatide constipation FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Sources
- US prescribing information for tirzepatide (Zepbound and Mounjaro), Eli Lilly and Company — dosing, storage, warnings and contraindications.
- SURMOUNT-1 — tirzepatide once weekly for the treatment of obesity, NCT04184622.
- SURPASS-2 — tirzepatide versus semaglutide 1 mg in type 2 diabetes, NCT03987919.
- Full source ledger — every primary source with a live link, what it supports, the date we read it, and the claims we deliberately do not source.